Oct. 15, 2024 — Alzheimer's disease may damage the brain in two distinct phases, based on new research using sophisticated brain mapping tools. According to researchers who discovered this new ...

This breakthrough could eventually lead to treatments for diseases like frontotemporal dementia and Alzheimer's disease.

(Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer ... for AL001 treatment of dementia related to Alzheimer ...

“The GP will first rule out any other medical condition that ... “There are no specific treatments for vascular dementia, however medications may be prescribed to reduce the risk of further ...

Hospice services can ease the transition to end-of-life care, supplying equipment and treatments that bring greater comfort and make it easier to care for a person in this stage. Dementia is not a ...

Alzamend’s novel AL001 formulation, a lithium-salicylate/L-proline engineered ionic cocrystal, is designed to overcome the toxicities associated with conventional lithium salts, promising a ...

Professor Craig Ritchie also predicts that significant advancements in treatment and early detection will lead to a substantial reduction in advanced cases of dementia. He stated: "I don't just ...

Oct. 3, 2024 — Researchers have identified individuals with increased risk for dementia using mobility data, recorded during a smartphone-based way-finding task on the university campus.

There are over 20,000 people with dementia in Northern Ireland. People with dementia here are more likely to get a diagnosis than anywhere else in the UK, but there is still a huge amount to do to ...

Bipolar disorder has potential links to memory changes during and after depressive or manic episodes. Learn how states and ...